UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 226

Sortiert nach

Epidemiological and clinical features of pediatric COVID-19

BMC medicine, 2020-08, Vol.18 (1), p.250-250, Article 250

2020

Volltextzugriff (PDF)

Reprogramming the tumor microenvironment by genome editing for precision cancer therapy

Molecular cancer, 2022-04, Vol.21 (1), p.98-98, Article 98

2022

Volltextzugriff (PDF)

Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer

BMC genomics, 2017-11, Vol.18 (1), p.901-901, Article 901

2017

Volltextzugriff (PDF)

MASS SPECTROMETRY‐BASED PERSONALIZED DRUG THERAPY

Mass spectrometry reviews, 2020-09, Vol.39 (5-6), p.523-552

2020

Volltextzugriff (PDF)

Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy

IUBMB life, 2018-03, Vol.70 (3), p.183-191

2018

Volltextzugriff (PDF)

Genome-scale analysis identifies NEK2, DLGAP5 and ECT2 as promising diagnostic and prognostic biomarkers in human lung cancer

Scientific reports, 2017-08, Vol.7 (1), p.8072-11, Article 8072

2017

Volltextzugriff (PDF)

Disruption of Iron Homeostasis to Induce Ferroptosis with Albumin‐Encapsulated Pt(IV) Nanodrug for the Treatment of Non‐Small Cell Lung Cancer

Small (Weinheim an der Bergstrasse, Germany), 2023-12, Vol.19 (49), p.e2206688-n/a

2023

Volltextzugriff (PDF)

eIF3a: A new anticancer drug target in the eIF family

Cancer letters, 2018-01, Vol.412, p.81-87

2018

Volltextzugriff (PDF)

Possible Strategies to Make Warfarin Dosing Algorithm Prediction More Accurately in Patients With Extreme Dose

Clinical pharmacology and therapeutics, 2018-02, Vol.103 (2), p.184-184

2018

Volltextzugriff (PDF)

Resistin facilitates metastasis of lung adenocarcinoma through the TLR4/Src/EGFR/PI3K/NF‐κB pathway

Cancer science, 2018-08, Vol.109 (8), p.2391-2400

2018

Volltextzugriff (PDF)

Remdesivir and COVID-19

The Lancet (British edition), 2020-10, Vol.396 (10256), p.953-954

2020

Volltextzugriff (PDF)

MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway

Scientific reports, 2017-01, Vol.7 (1), p.40384, Article 40384

2017

Volltextzugriff (PDF)

The role of CSDE1 in translational reprogramming and human diseases

Cell communication and signaling, 2020-01, Vol.18 (1), p.14-14, Article 14

2020

Volltextzugriff (PDF)

Gut microbial structural variation associates with immune checkpoint inhibitor response

Nature communications, 2023-11, Vol.14 (1), p.7421-7421, Article 7421

2023

Volltextzugriff (PDF)

LncRNA FOXD1‐AS1 acts as a potential oncogenic biomarker in glioma

CNS neuroscience & therapeutics, 2020-01, Vol.26 (1), p.66-75

2020

Volltextzugriff (PDF)

Hsa_circ_0001946 Inhibits Lung Cancer Progression and Mediates Cisplatin Sensitivity in Non-small Cell Lung Cancer via the Nucleotide Excision Repair Signaling Pathway

Frontiers in oncology, 2019-06, Vol.9, p.508-508

2019

Volltextzugriff (PDF)

A New Way to Discover IRESs in Pathology or Stress Conditions? Harnessing Latest High‐Throughput Technologies

BioEssays, 2020-03, Vol.42 (3), p.e1900180-n/a

2020

Volltextzugriff (PDF)

The Prospective Value of Dopamine Receptors on Bio-Behavior of Tumor

Journal of Cancer, 2019-01, Vol.10 (7), p.1622-1632

2019

Volltextzugriff (PDF)

HLA-targeted sequencing reveals the pathogenic role of HLA-B15:02/HLA-B13:01 in albendazole-induced liver failure: a case report and a review of the literature

Frontiers in pharmacology, 2023-11, Vol.14

2023

Volltextzugriff (PDF)

Genetic Polymorphisms and Platinum-based Chemotherapy Treatment Outcomes in Patients with Non-Small Cell Lung Cancer: A Genetic Epidemiology Study Based Meta-analysis

Scientific reports, 2017-07, Vol.7 (1), p.5593-19, Article 5593

2017

Volltextzugriff (PDF)

Precision dosing of warfarin: open questions and strategies

The pharmacogenomics journal, 2019-06, Vol.19 (3), p.219-229

2019

Volltextzugriff (PDF)

The role of single strand break repair pathways in cellular responses to camptothecin induced DNA damage

Biomedicine & pharmacotherapy, 2020-05, Vol.125, p.109875, Article 109875

2020

Volltextzugriff (PDF)

B.1.617.2 (Delta) Variant of SARS-CoV-2: features, transmission and potential strategies

International journal of biological sciences, 2022-01, Vol.18 (5), p.1844-1851

2022

Volltextzugriff (PDF)

Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP‐binding cassette subfamily C member 2 (ABCC2) with platinum‐based chemotherapy response and toxicity in non‐small cell lung cancer patients

Ai zheng, 2016-09, Vol.35 (1), p.1-13, Article 85

2016

Volltextzugriff (PDF)

Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer

International journal of molecular sciences, 2016-06, Vol.17 (6), p.839-839

2016

Volltextzugriff (PDF)

1 – 25 von 226

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(208)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Epidemiological and clinical features of pediatric COVID-19

Reprogramming the tumor microenvironment by genome editing for precision cancer therapy

Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer

MASS SPECTROMETRY‐BASED PERSONALIZED DRUG THERAPY

Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy

Genome-scale analysis identifies NEK2, DLGAP5 and ECT2 as promising diagnostic and prognostic biomarkers in human lung cancer

Disruption of Iron Homeostasis to Induce Ferroptosis with Albumin‐Encapsulated Pt(IV) Nanodrug for the Treatment of Non‐Small Cell Lung Cancer

eIF3a: A new anticancer drug target in the eIF family

Possible Strategies to Make Warfarin Dosing Algorithm Prediction More Accurately in Patients With Extreme Dose

Resistin facilitates metastasis of lung adenocarcinoma through the TLR4/Src/EGFR/PI3K/NF‐κB pathway

Remdesivir and COVID-19

MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway

The role of CSDE1 in translational reprogramming and human diseases

Gut microbial structural variation associates with immune checkpoint inhibitor response

LncRNA FOXD1‐AS1 acts as a potential oncogenic biomarker in glioma

Hsa_circ_0001946 Inhibits Lung Cancer Progression and Mediates Cisplatin Sensitivity in Non-small Cell Lung Cancer via the Nucleotide Excision Repair Signaling Pathway

A New Way to Discover IRESs in Pathology or Stress Conditions? Harnessing Latest High‐Throughput Technologies

The Prospective Value of Dopamine Receptors on Bio-Behavior of Tumor

HLA-targeted sequencing reveals the pathogenic role of HLA-B15:02/HLA-B13:01 in albendazole-induced liver failure: a case report and a review of the literature

Genetic Polymorphisms and Platinum-based Chemotherapy Treatment Outcomes in Patients with Non-Small Cell Lung Cancer: A Genetic Epidemiology Study Based Meta-analysis

Precision dosing of warfarin: open questions and strategies

The role of single strand break repair pathways in cellular responses to camptothecin induced DNA damage

B.1.617.2 (Delta) Variant of SARS-CoV-2: features, transmission and potential strategies

Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP‐binding cassette subfamily C member 2 (ABCC2) with platinum‐based chemotherapy response and toxicity in non‐small cell lung cancer patients

Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer

Suchergebnisse filtern